Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Dose Escalation and Feasibility Study of Amrubicin Combined With Cisplatin in Previously Untreated Patients With Advanced Non-small-cell Lung Cancer.
Yoshimura N, Kimura T, Mitsuoka S, Kyoh S, Tochino Y, Asai K, Ichimaru Y, Hirata K, Kudoh S.
Am J Clin Oncol. 2012 Jan 19. [Epub ahead of print]
Related citations
Can Serum be Used for Analyzing the EGFR Mutation Status in Patients with Advanced Non-small Cell Lung Cancer?
Kim ST, Jung HY, Sung JS, Jo UH, Tanaka T, Hagiwara K, Park KH, Shin SW, Kim JS, Kim YH.
Am J Clin Oncol. 2012 Jan 10. [Epub ahead of print]
ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.
Decker RH, Langer CJ, Rosenzweig KE, Chang JY, Gewanter RM, Ginsburg ME, Kong FM, Lally BE, Videtic GM, Movsas B.
Am J Clin Oncol. 2011 Oct;34(5):537-44. Review.
Noninferiority Trials in Second-Line Treatments of Nonsmall Cell Lung Cancer: A Systematic Review of Literature With Meta-analysis of Phase III Randomized Clinical Trials.
Tassinari D, Scarpi E, Sartori S, Drudi F, Castellani C, Carloni F, Tombesi P, Lazzari-Agli L.
Am J Clin Oncol. 2011 Sep 16. [Epub ahead of print]
Phase I study of pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer.
Li BS, Gong HY, Huang W, Yi Y, Yu JM, Wang ZT, Zhang ZC, Sun HF, Li HS, Wang LY.
Am J Clin Oncol. 2012 Apr;35(2):115-9.
Wait Times in Diagnostic Evaluation and Treatment for Patients With Stage III Non-Small Cell Lung Cancer in British Columbia.
Wai ES, Mackinnon M, Hooker R, Moccia P, Perry KR, Truong PT.
Am J Clin Oncol. 2011 Mar 18. [Epub ahead of print]
Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment.
Glattki GP, Manika K, Sichletidis L, Alexe G, Brenke R, Spyratos D.
Am J Clin Oncol. 2012 Apr;35(2):120-5.
Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004.
Saito H, Nakagawa K, Takeda K, Iwamoto Y, Ando M, Maeda M, Katakami N, Nakano T, Kurata T, Fukuoka M.
Am J Clin Oncol. 2012 Feb;35(1):58-63.
A pilot study of bevacizumab and interferon-α2b in ocular melanoma.
Guenterberg KD, Grignol VP, Relekar KV, Varker KA, Chen HX, Kendra KL, Olencki TE, Carson WE 3rd.
Am J Clin Oncol. 2011 Feb;34(1):87-91.
Predictive ability of Charlson comorbidity index on outcomes from lung cancer.
Ganti AK, Siedlik E, Marr AS, Loberiza FR Jr, Kessinger A.
Am J Clin Oncol. 2011 Dec;34(6):593-6. doi: 10.1097/COC.0b013e3181fe445b.
Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
Lanni TB Jr, Grills IS, Kestin LL, Robertson JM.
Am J Clin Oncol. 2011 Oct;34(5):494-8.
Genealogical tree study as screening method in the Lynch syndrome prior to genetic test.
Delgado-Plasencia L, Medina-Arana V, Barrios Del Pino Y, Fernández-Peralta A, González-Aguilera JJ.
Am J Clin Oncol. 2010 Aug;33(4):376-80.
Identifying subsets of metastatic breast cancer patients likely to benefit from treatment with the epothilone B analog ixabepilone.
Harichand-Herdt S, O'regan RM.
Am J Clin Oncol. 2010 Dec;33(6):561-7. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on